LUMASIRAN DEMONSTRATED COMPARABLE OXALATE REDUCTION AND SAFETY IN CHILDREN AND ADULTS WITH PRIMARY HYPEROXALURIA TYPE 1

被引：0

作者：

Shasha-Lavsky, Hadas ^{[1
]}

Garrelfs, Sander ^{[2
]}

Sas, David ^{[3
]}

Lieske, John ^{[4
]}

Ngo, Taylor ^{[5
]}

Makarova, Nune ^{[5
]}

Gansner, John ^{[5
]}

McGregor, Tracy ^{[5
]}

Frishberg, Yaacov ^{[6
]}

机构：

[1] Galilee Med Ctr, Pediat Nephrol Unit, Nahariyya, Israel

[2] Univ Amsterdam, Amsterdam UMC, Emma Childrens Hosp, Amsterdam, Netherlands

[3] Mayo Clin, Div Pediat Nephrol & Hypertens, Rochester, MN USA

[4] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA

[5] Alnylam Pharmaceut, Cambridge, MA USA

[6] Shaare Zedek Med Ctr, Div Pediat Nephrol, Jerusalem, Israel

来源：

关键词：

D O I：

暂无

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

FC013

引用

页数：1